William Blair Reaffirms Outperform Rating for Pyxis Oncology (NASDAQ:PYXS)

William Blair restated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note released on Wednesday morning, RTT News reports. Separately, Royal Bank of Canada started coverage on shares of Pyxis Oncology in a research note on Tuesday, September 5th. They issued an outperform rating and a $7.00 price […]

Related Keywords

Blackrock ,Nova Scotia ,Canada ,Klara Sullivan ,William Blair ,Citadel Advisors ,Pyxis Oncology Inc ,Vanguard Group Inc ,Royal Bank ,Blackrock Inc ,Nasdaq ,Tower Research Capital ,Prelude Capital Management ,Pyxis Oncology ,Free Report ,Get Free Report ,Research Capital ,Pyxis Oncology Daily ,Nasdaq Pyxs ,Pyxs ,Medical ,Reiterated Rating ,